NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

Biosect, I agree. Advent has a large (70+ has been mentioned here) payroll of highly trained employees. Most of them will be needed to start working on producing DcVax as soon as NWBO gets approved for commercial production. Not sure how rapid the ramp will be but NWBO has to have enough mfg in place from day 1 of commercial production to convince the RA that NWBO can meet the demand for DcVax when they approve it. In the meantime, those staff can't be assigned to producing for other Advent customers on anything but a very short-term basis, because they have to be available to service DcVax demand now (Specials) and as when commercial production rapidly increases the demand. The Specials program has to be supporting the Advent monthly payroll. We don't know what the Specials costs are now nor do we know anything specific about Advents payroll other than what we can guess it's costing them to carry their fairly large staff of specialists.